Annual CFI
-$199.19 M
-$339.80 M-241.67%
December 31, 2024
Summary
- As of March 13, 2025, TARS annual cash flow from investing activities is -$199.19 million, with the most recent change of -$339.80 million (-241.67%) on December 31, 2024.
- During the last 3 years, TARS annual CFI has fallen by -$198.61 million (-33892.32%).
- TARS annual CFI is now -241.67% below its all-time high of $140.60 million, reached on December 31, 2023.
Performance
TARS Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$59.57 M
-$62.70 M-2004.54%
December 31, 2024
Summary
- As of March 13, 2025, TARS quarterly cash flow from investing activities is -$59.57 million, with the most recent change of -$62.70 million (-2004.54%) on December 31, 2024.
- Over the past year, TARS quarterly CFI has dropped by -$62.70 million (-2004.54%).
- TARS quarterly CFI is now -192.95% below its all-time high of $64.09 million, reached on June 30, 2023.
Performance
TARS Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$199.19 M
-$77.42 M-63.58%
December 31, 2024
Summary
- As of March 13, 2025, TARS TTM cash flow from investing activities is -$199.19 million, with the most recent change of -$77.42 million (-63.58%) on December 31, 2024.
- Over the past year, TARS TTM CFI has dropped by -$77.42 million (-63.58%).
- TARS TTM CFI is now -241.67% below its all-time high of $140.60 million, reached on December 31, 2023.
Performance
TARS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
TARS Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -241.7% | -2004.5% | -63.6% |
| 3 y3 years | -10000.0% | -10000.0% | -10000.0% |
| 5 y5 years | -10000.0% | - | - |
TARS Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -241.7% | at low | -192.9% | +41.7% | -241.7% | at low |
| 5 y | 5-year | -241.7% | at low | -192.9% | +41.7% | -241.7% | at low |
| alltime | all time | -241.7% | at low | -192.9% | +41.7% | -241.7% | at low |
Tarsus Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$199.19 M(-241.7%) | -$59.57 M(-2004.5%) | -$199.19 M(+63.6%) |
| Sep 2024 | - | $3.13 M(-107.7%) | -$121.77 M(+57.1%) |
| Jun 2024 | - | -$40.52 M(-60.4%) | -$77.53 M(-386.2%) |
| Mar 2024 | - | -$102.22 M(-672.7%) | $27.09 M(-80.7%) |
| Dec 2023 | $140.60 M(-197.2%) | $17.85 M(-62.3%) | $140.60 M(+295.7%) |
| Sep 2023 | - | $47.37 M(-26.1%) | $35.53 M(-151.5%) |
| Jun 2023 | - | $64.09 M(+467.5%) | -$68.96 M(-48.2%) |
| Mar 2023 | - | $11.29 M(-112.9%) | -$133.17 M(-7.9%) |
| Dec 2022 | -$144.63 M | -$87.22 M(+52.7%) | -$144.63 M(+150.7%) |
| Sep 2022 | - | -$57.13 M(>+9900.0%) | -$57.68 M(+8408.0%) |
| Jun 2022 | - | -$122.00 K(-24.2%) | -$678.00 K(+18.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$161.00 K(-41.2%) | -$572.00 K(-2.4%) |
| Dec 2021 | -$586.00 K(+28.5%) | -$274.00 K(+126.4%) | -$586.00 K(+123.7%) |
| Sep 2021 | - | -$121.00 K(+656.3%) | -$262.00 K(-5.1%) |
| Jun 2021 | - | -$16.00 K(-90.9%) | -$276.00 K(-53.6%) |
| Mar 2021 | - | -$175.00 K(-450.0%) | -$595.00 K(+30.5%) |
| Dec 2020 | -$456.00 K(+160.6%) | $50.00 K(-137.0%) | -$456.00 K(-9.9%) |
| Sep 2020 | - | -$135.00 K(-59.7%) | -$506.00 K(+36.4%) |
| Jun 2020 | - | -$335.00 K(+830.6%) | -$371.00 K(+930.6%) |
| Mar 2020 | - | -$36.00 K | -$36.00 K |
| Dec 2019 | -$175.00 K(+2400.0%) | - | - |
| Dec 2018 | -$7000.00 | - | - |
FAQ
- What is Tarsus Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual CFI year-on-year change?
- What is Tarsus Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly CFI year-on-year change?
- What is Tarsus Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals TTM CFI year-on-year change?
What is Tarsus Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of TARS is -$199.19 M
What is the all time high annual CFI for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual cash flow from investing activities is $140.60 M
What is Tarsus Pharmaceuticals annual CFI year-on-year change?
Over the past year, TARS annual cash flow from investing activities has changed by -$339.80 M (-241.67%)
What is Tarsus Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of TARS is -$59.57 M
What is the all time high quarterly CFI for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly cash flow from investing activities is $64.09 M
What is Tarsus Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, TARS quarterly cash flow from investing activities has changed by -$62.70 M (-2004.54%)
What is Tarsus Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of TARS is -$199.19 M
What is the all time high TTM CFI for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high TTM cash flow from investing activities is $140.60 M
What is Tarsus Pharmaceuticals TTM CFI year-on-year change?
Over the past year, TARS TTM cash flow from investing activities has changed by -$77.42 M (-63.58%)